NLM Logo

LALA 87 protocol MeSH Supplementary Concept Data 2024


MeSH Supplementary
LALA 87 protocol
Unique ID
C079907
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C079907
Entry Term(s)
French Acute Lymphoblastic Leukemia Protocol: LALA 87
Registry Number
0
Heading Mapped to
*Antineoplastic Combined Chemotherapy Protocols
Cyclophosphamide
Daunorubicin / *analogs & derivatives
Methotrexate
Steroids
Vincristine
Frequency
4
Note
chemotherapy protocol consisting of zorubicine, vincristine, cyclophosphamide, methotrexate & steroids; used in treatment of acute lymphoblastic leukemia
Source
Leuk Lymphoma 1992 Nov;8(4-5):415-9
Date of Entry
1993/03/26
Revision Date
2013/11/06
LALA 87 protocol Preferred
French Acute Lymphoblastic Leukemia Protocol: LALA 87 Narrower
page delivered in 0.005s